{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:08:17Z","timestamp":1780463297687,"version":"3.54.1"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Over the past several years, research and technologies involving patient-derived induced pluripotent stem cells (iPSCs) have rapidly advanced, enabling the study of various disease pathologies, including rare pathologies like monogenic disorders of beta cell function. iPSCs offer a unique model to study monogenic beta cell disorders such as Maturity-onset diabetes of the young (MODY) and congenital hyperinsulinism as they can be derived directly from patients with novel genetic variants and then differentiated into pancreatic progenitors and beta cells. Studies have used iPSC-derived SC-islets to demonstrate how transcription factor dysfunction can perturb insulin secretion, beta cell maturation, and endocrine lineage specification in MODY subtypes. Additional studies in congenital hyperinsulinism have utilized iPSC-derived SC-islets to model disease-specific hallmarks such as excess insulin secretion and increased beta cell proliferation. These studies provide the foundation for future studies using iPSC-derived SC-islets as a platform for elucidating mechanisms of how single-gene variants disrupt beta cell specification, maturation, and survival.<\/jats:p>","DOI":"10.3389\/fendo.2026.1819394","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:49:59Z","timestamp":1780462199000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-derived induced pluripotent stem cells for precision modelling of monogenic beta cell disorders"],"prefix":"10.3389","volume":"17","author":[{"given":"Lily","family":"Deng","sequence":"first","affiliation":[{"name":"Division of Diabetes and Endocrinology, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine","place":["Cincinnati, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansa","family":"Krishnamurthy","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine","place":["Cincinnati, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/genes17020215","article-title":"Review article: Overview of clinical genetics of diabetes mellitus","volume":"17","author":"Asamoah","year":"2026","journal-title":"Genes (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/life16030399","article-title":"The genetic landscape of diabetes mellitus: Lessons from monogenic and polygenic forms","volume":"16","author":"Nilo","year":"2026","journal-title":"Life (Basel)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf172","article-title":"Maturity onset diabetes of the young and beyond: The changing face of single-gene diabetes","volume":"193","author":"Laver","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/jci142244","article-title":"Monogenic diabetes: A gateway to precision medicine in diabetes","volume":"131","author":"Zhang","year":"2021","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa710","article-title":"Approach to the patient with MODY-monogenic diabetes","volume":"106","author":"Broome","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4274\/jcrpe.2017.s007","article-title":"Congenital hyperinsulinism: Diagnosis and treatment update","volume":"9","author":"Demirbilek","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31737","article-title":"Congenital hyperinsulinism disorders: Genetic and clinical characteristics","volume":"181","author":"Rosenfeld","year":"2019","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14728","article-title":"Neonatal diabetes caused by disrupted pancreatic and beta-cell development","volume":"38","author":"De Franco","year":"2021","journal-title":"Diabetes Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/db19-330-lb","article-title":"Using human induced pluripotent stem cell-derived organoids to identify new pathologies in patients with PDX1 mutations","volume":"163","author":"Krishnamurthy","year":"2022","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-59745-443-8_3","article-title":"Human embryonic stem cells for tissue engineering","volume":"140","author":"Kitsberg","year":"2007","journal-title":"Methods Mol Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-62703-348-0_3","article-title":"A review of the methods for human iPSC derivation","volume":"997","author":"Malik","year":"2013","journal-title":"Methods Mol Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/febs.13110","article-title":"Genome modification by CRISPR\/CAS9","volume":"281","author":"Ma","year":"2014","journal-title":"FEBS J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100238","article-title":"Applications of iPSC-derived beta cells from patients with diabetes","volume":"2","author":"Maxwell","year":"2021","journal-title":"Cell Rep Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2025.06.015","article-title":"Global research dynamics in the induced pluripotent stem cell and diabetes: A bibliometric analysis of the past twenty years","volume":"30","author":"Wang","year":"2025","journal-title":"Regener Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1625439","article-title":"Navigating challenges in human pluripotent stem cell-derived islet therapy for type 1 diabetes","volume":"16","author":"Usama","year":"2025","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2026.03.004","article-title":"Pre-adaptation of stem cell-derived islet organoids to hypoxia via zinc transportation inhibition drives angiogenesis","volume":"33","author":"Wang","year":"2026","journal-title":"Cell Stem Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2023.04.002","article-title":"Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes","volume":"30","author":"Hogrebe","year":"2023","journal-title":"Cell Stem Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01219-z","article-title":"Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells","volume":"40","author":"Balboa","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-021-00560-y","article-title":"Generation of insulin-producing pancreatic beta cells from multiple human stem cell lines","volume":"16","author":"Hogrebe","year":"2021","journal-title":"Nat Protoc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of functional human pancreatic beta cells in vitro","volume":"159","author":"Pagliuca","year":"2014","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3033","article-title":"Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells","volume":"32","author":"Rezania","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1101\/2025.10.31.685661","article-title":"Human pancreatic organoids derived from pluripotent stem cells recapitulate pancreatic organogenesis","volume-title":"bioRxiv","author":"Brassard","year":"2025"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2024.151464","article-title":"Exploring optimal protocols for generating and preserving glucose-responsive insulin-secreting progenitor cells derived from human pluripotent stem cells","volume":"103","author":"Tornabene","year":"2024","journal-title":"Eur J Cell Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvag064","article-title":"A worldwide perspective on clinical characteristics and treatment of youth with monogenic diabetes in the SWEET registry","volume":"10","author":"Deng","year":"2026","journal-title":"J Endocr Soc"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2025.100398","article-title":"Genetic variants and characterization of MODY in a single, large pediatric referral center","volume":"40","author":"Deng","year":"2025","journal-title":"J Clin Transl Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13426","article-title":"ISPAD clinical practice consensus guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents","volume":"23","author":"Greeley","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.52717","article-title":"Australian and New Zealand joint society consensus statement on genetic testing for monogenic diabetes in adults","volume":"223","author":"De Sousa","year":"2025","journal-title":"Med J Aust"},{"key":"B29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.scr.2018.06.013","article-title":"Derivation and molecular characterization of pancreatic differentiated MODY1-iPSCs","volume":"31","author":"Braverman-Gross","year":"2018","journal-title":"Stem Cell Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.isci.2019.05.032","article-title":"HNF4A haploinsufficiency in MODY1 abrogates liver and pancreas differentiation from patient-derived induced pluripotent stem cells","volume":"16","author":"Ng","year":"2019","journal-title":"iScience"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2337\/figshare.17836400.v1","article-title":"Spatial environment affects HNF4A mutation-specific proteome signatures and cellular morphology in hiPSC-derived beta-like cells","volume":"71","author":"Carrasco","year":"2022","journal-title":"Diabetes"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.c112.428979","article-title":"Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young","volume":"288","author":"Teo","year":"2013","journal-title":"J Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217110","article-title":"Expression of mutant mRNA and protein in pancreatic cells derived from MODY3- iPS cells","volume":"14","author":"Yabe","year":"2019","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110425","article-title":"An HNF1alpha truncation associated with maturity-onset diabetes of the young impairs pancreatic progenitor differentiation by antagonizing HNF1beta function","volume":"38","author":"Cujba","year":"2022","journal-title":"Cell Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.molmet.2019.03.006","article-title":"Point mutations in the PDX1 transactivation domain impair human beta-cell development and function","volume":"24","author":"Wang","year":"2019","journal-title":"Mol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06232-2","article-title":"Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1(+)\/NKX6.1(+) progenitors","volume":"67","author":"Aldous","year":"2024","journal-title":"Diabetologia"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1242\/dev.194878","article-title":"Mitchell-Riley syndrome iPSCs exhibit reduced pancreatic endoderm differentiation due to a mutation in RFX6","volume":"147","author":"Trott","year":"2020","journal-title":"Development"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03390-8","article-title":"Aberrant development of pancreatic beta cells derived from human iPSCs with FOXA2 deficiency","volume":"12","author":"Elsayed","year":"2021","journal-title":"Cell Death Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.03.055","article-title":"An activating STAT3 mutation causes neonatal diabetes through premature induction of pancreatic differentiation","volume":"19","author":"Saarimaki-Vire","year":"2017","journal-title":"Cell Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101853","article-title":"Insulin regulates human pancreatic endocrine cell differentiation in vitro","volume":"79","author":"Cota","year":"2024","journal-title":"Mol Metab"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s44321-025-00362-9","article-title":"A new form of diabetes caused by INS mutations defined by zygosity, stem cell and population data","volume":"18","author":"Tong","year":"2026","journal-title":"EMBO Mol Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"8824","DOI":"10.3390\/ijms23158824","article-title":"Aberrant splicing of INS impairs beta-cell differentiation and proliferation by ER stress in the isogenic iPSC model of neonatal diabetes","volume":"23","author":"Panova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2017.01.001","article-title":"Genome editing in hPSCs reveals GATA6 haploinsufficiency and a genetic interaction with GATA4 in human pancreatic development","volume":"20","author":"Shi","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.stemcr.2016.12.026","article-title":"GATA6 plays an important role in the induction of human definitive endoderm, development of the pancreas, and functionality of pancreatic beta cells","volume":"8","author":"Tiyaboonchai","year":"2017","journal-title":"Stem Cell Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2024.103389","article-title":"Generation and characterization of an induced pluripotent stem cell (iPSC) line SDQLCHi063-A from peripheral blood mononuclear cells of a patient with maturity-onset diabetes of the young type 2 carrying GCK exon 1 deletion","volume":"77","author":"Gao","year":"2024","journal-title":"Stem Cell Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.101991","article-title":"Generation of two human iPSC lines from patients with maturity-onset diabetes of the young type 2 (MODY2) and permanent neonatal diabetes due to mutations in the GCK gene","volume":"48","author":"Aqel","year":"2020","journal-title":"Stem Cell Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1038\/s41467-021-22843-4","article-title":"Decreased GLUT2 and glucose uptake contribute to insulin secretion defects in MODY3\/HNF1A hiPSC-derived mutant beta cells","volume":"12","author":"Low","year":"2021","journal-title":"Nat Commun"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2019.07.007","article-title":"Modeling monogenic diabetes using human ESCs reveals developmental and metabolic deficiencies caused by mutations in HNF1A","volume":"25","author":"Cardenas-Diaz","year":"2019","journal-title":"Cell Stem Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2018.02.017","article-title":"Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 3 (MODY3) carrying a hepatocyte nuclear factor 1-alpha (HNF1A) mutation","volume":"29","author":"Griscelli","year":"2018","journal-title":"Stem Cell Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molmet.2018.01.011","article-title":"Genome-wide analysis of PDX1 target genes in human pancreatic progenitors","volume":"9","author":"Wang","year":"2018","journal-title":"Mol Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12334","article-title":"Establishment of maturity-onset diabetes of the young-induced pluripotent stem cells from a Japanese patient","volume":"6","author":"Yabe","year":"2015","journal-title":"J Diabetes Invest"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2016.01.007","article-title":"Early developmental perturbations in a human stem cell model of MODY5\/HNF1B pancreatic hypoplasia","volume":"6","author":"Teo","year":"2016","journal-title":"Stem Cell Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2021.07.018","article-title":"Modeling HNF1B-associated monogenic diabetes using human iPSCs reveals an early stage impairment of the pancreatic developmental program","volume":"16","author":"El-Khairi","year":"2021","journal-title":"Stem Cell Rep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2017.07.023","article-title":"Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 13 (MODY13) with a the potassium inwardly-rectifying channel, subfamily J, member 11 (KCNJ11) mutation","volume":"23","author":"Griscelli","year":"2017","journal-title":"Stem Cell Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa986","article-title":"Generation of beta cells from iPSC of a MODY8 patient with a novel mutation in the carboxyl ester lipase (CEL) gene","volume":"106","author":"Pellegrini","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1038\/s41598-017-03349-w","article-title":"Modeling congenital hyperinsulinism with ABCC8-deficient human embryonic stem cells generated by CRISPR\/Cas9","volume":"7","author":"Guo","year":"2017","journal-title":"Sci Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05346-7","article-title":"SUR1-mutant iPS cell-derived islets recapitulate the pathophysiology of congenital hyperinsulinism","volume":"64","author":"Lithovius","year":"2021","journal-title":"Diabetologia"},{"key":"B58","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00125-025-06605-1","article-title":"Modelling the effects of human SUR1 R1420H variation on insulin secretory function using isogenic iPSC-derived pancreatic islets","volume":"69","author":"Nair","year":"2026","journal-title":"Diabetologia"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1819394\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:50:05Z","timestamp":1780462205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1819394\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":58,"alternative-id":["10.3389\/fendo.2026.1819394"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1819394","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1819394"}}